Free Trial

Neogen (NEOG) Competitors

Neogen logo
$5.65 +0.15 (+2.78%)
As of 10:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WST

Should you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

Neogen vs. Its Competitors

Haemonetics (NYSE:HAE) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Haemonetics has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.77, suggesting that its stock price is 77% more volatile than the S&P 500.

Haemonetics presently has a consensus price target of $97.30, suggesting a potential upside of 23.24%. Neogen has a consensus price target of $7.50, suggesting a potential upside of 32.67%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
2 Strong Buy rating(s)
3.00
Neogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by insiders. Comparatively, 1.1% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Haemonetics had 2 more articles in the media than Neogen. MarketBeat recorded 9 mentions for Haemonetics and 7 mentions for Neogen. Haemonetics' average media sentiment score of 1.27 beat Neogen's score of 0.06 indicating that Haemonetics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Neogen
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haemonetics$1.36B2.79$167.68M$3.3123.85
Neogen$906.00M1.35-$9.42M-$2.23-2.53

Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Haemonetics12.32% 26.37% 9.22%
Neogen -53.56%2.69%1.82%

Summary

Haemonetics beats Neogen on 15 of the 17 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

MetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.23B$10.48B$5.55B$8.99B
Dividend YieldN/A2.09%5.25%4.03%
P/E Ratio-2.5316.4327.4420.13
Price / Sales1.3531.21414.93172.83
Price / Cash5.1122.7937.0657.97
Price / Book0.393.728.135.61
Net Income-$9.42M$235.43M$3.16B$248.50M
7 Day Performance6.16%2.12%2.92%4.36%
1 Month Performance-3.20%2.27%3.14%6.87%
1 Year Performance-62.74%-11.14%33.91%20.78%

Neogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
4.0853 of 5 stars
$5.65
+2.8%
$7.50
+32.7%
-62.7%$1.23B$906.00M-2.532,110
HAE
Haemonetics
4.8774 of 5 stars
$74.77
+1.3%
$96.80
+29.5%
-7.7%$3.59B$1.36B22.593,023News Coverage
Positive News
Analyst Upgrade
Analyst Revision
Gap Up
ICUI
ICU Medical
4.5317 of 5 stars
$132.15
+0.3%
$192.67
+45.8%
+12.9%$3.25B$2.38B-34.5015,000Positive News
XRAY
DENTSPLY SIRONA
4.4417 of 5 stars
$15.88
-0.3%
$20.36
+28.2%
-31.5%$3.16B$3.79B-3.5014,000
QDEL
QuidelOrtho
4.4416 of 5 stars
$28.82
-0.2%
$44.33
+53.8%
+5.2%$1.95B$2.78B-5.806,600
STAA
STAAR Surgical
3.8351 of 5 stars
$16.78
-0.8%
$24.63
+46.8%
-58.7%$831.11M$313.90M-11.651,211
CERS
Cerus
3.2023 of 5 stars
$1.41
-0.7%
$3.50
+148.2%
-24.7%$269.54M$180.27M-14.10290Positive News
OSUR
OraSure Technologies
1.8231 of 5 stars
$3.00
-0.3%
$3.00
-26.1%$224.40M$185.83M-7.14840News Coverage
UTMD
Utah Medical Products
1.6396 of 5 stars
$56.92
-1.5%
N/A-13.4%$184.99M$40.90M15.06180News Coverage
Positive News
ANIK
Anika Therapeutics
3.7544 of 5 stars
$10.58
-1.5%
$20.00
+89.0%
-57.1%$151.72M$119.91M-2.73300Positive News
WST
West Pharmaceutical Services
4.7459 of 5 stars
$218.80
0.0%
$320.00
+46.3%
-29.0%$15.72B$2.89B34.3510,600

Related Companies and Tools


This page (NASDAQ:NEOG) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners